| Microfluidic formulation of DNA-loaded multicomponent lipid nanoparticles for gene delivery E Quagliarini, S Renzi, L Digiacomo, F Giulimondi, B Sartori, H Amenitsch, ... Pharmaceutics 13 (8), 1292, 2021 | 36 | 2021 |
| Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer C Bartolacci, C Andreani, C Curcio, S Occhipinti, L Massaccesi, ... Cancer Immunology Research 6 (12), 1486-1498, 2018 | 31 | 2018 |
| In vitro and in vivo studies of gold (I) azolate/phosphane complexes for the treatment of basal like breast cancer V Gambini, M Tilio, EW Maina, C Andreani, C Bartolacci, J Wang, M Iezzi, ... European journal of medicinal chemistry 155, 418-427, 2018 | 28 | 2018 |
| Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib M Tilio, V Gambini, J Wang, C Garulli, C Kalogris, C Andreani, ... Cancer Letters 381 (1), 76-84, 2016 | 25 | 2016 |
| Efficient delivery of DNA using lipid nanoparticles L Cui, S Renzi, E Quagliarini, L Digiacomo, H Amenitsch, L Masuelli, ... Pharmaceutics 14 (8), 1698, 2022 | 20 | 2022 |
| Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice J Wang, R Iannarelli, S Pucciarelli, E Laudadio, R Galeazzi, M Giangrossi, ... Pharmacological Research 161, 105123, 2020 | 16 | 2020 |
| HER2-displaying M13 bacteriophages induce therapeutic immunity against breast cancer J Wang, A Lamolinara, L Conti, M Giangrossi, L Cui, MB Morelli, ... Cancers 14 (16), 4054, 2022 | 15 | 2022 |
| Multi-targeted anticancer activity of imidazolate phosphane gold (I) compounds by inhibition of DHFR and TrxR in breast cancer cells R Galassi, L Luciani, V Gambini, S Vincenzetti, G Lupidi, A Amici, ... Frontiers in Chemistry 8, 602845, 2021 | 12 | 2021 |
| Mechanistic insights into the superior DNA delivery efficiency of multicomponent lipid nanoparticles: an in vitro and in vivo study E Quagliarini, J Wang, S Renzi, L Cui, L Digiacomo, G Ferri, L Pesce, ... ACS Applied Materials & Interfaces 14 (51), 56666-56677, 2022 | 11 | 2022 |
| Breast Cancer Treatment: The Case of Gold (I)-Based Compounds as a Promising Class of Bioactive Molecules R Galassi, L Luciani, J Wang, S Vincenzetti, L Cui, A Amici, S Pucciarelli, ... Biomolecules 12 (1), 80, 2022 | 11 | 2022 |
| The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells L Cui, E Quagliarini, S Xiao, F Giulimondi, S Renzi, L Digiacomo, ... Nanoscale Advances 4 (18), 4009-4015, 2022 | 8 | 2022 |
| Insights into the effect of polyethylene terephthalate (PET) microplastics on HER2 signaling pathways L Cui, L Digiacomo, S Xiao, J Wang, A Amici, D Pozzi, G Caracciolo, ... Toxicology in Vitro 91, 105632, 2023 | 5 | 2023 |
| Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer (vol 6, pg 1486, 2018) C Bartolacci, C Andreani, C Curcio, C Occhipinti, L Massaccesi, ... CANCER IMMUNOLOGY RESEARCH 7 (3), 526-526, 2019 | | 2019 |
